Home › Hereditary Sensory and Autonomic Neuropathies › Pennsylvania
Hereditary Sensory and Autonomic Neuropathies clinical trials in Pennsylvania
9 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06896188Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Temple University, Philadelphia
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
- Geisinger Health System, Lewisburg
RecruitingObservational study
All ages · All sexes · Updated Jul 23, 2026 · NCT01238250A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- University of Pennsylvania, Philadelphia
RecruitingPhase 1
Ages 18 and older · Women · Updated Apr 22, 2026 · NCT05683418Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 26, 2026 · NCT06599619Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- Alliance Cancer Specialists, PC, Doylestown
- West Penn Hospital, Pittsburgh
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 24, 2025 · NCT06463028The Cancer of the Pancreas Screening-5 CAPS5)Study
- University of Pennsylvania, Philadelphia
- University of Pittsburgh, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 9, 2025 · NCT02000089From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.